STAAR Surgical FY26 Q2 net income swings to USD 8.1 million; net sales more than doubled to USD 93.5 million year over year
STAA•Q2 2026 results
- STAAR Surgical posted Q2 2026 net sales of $93.5 million, more than doubled year over year.
- Net income swung to $8.1 million, or $0.16 per diluted share, from a year-ago net loss.
- Gross margin widened 0.5 percentage points to 74.5%.
- Non-GAAP adjusted EBITDA swung to $20 million, or $0.39 per diluted share, from a year-ago adjusted EBITDA loss.
- China net sales rose to $52.3 million; cash and investments climbed to $181.5 million, with no outstanding debt.
Related News
Hippo CEO Richard McCathron reports disposal of 5,000 common shares worth $160,000
HIPO•
International Tower Hill Mines releases corporate presentation on Livengood gold project development plan
THM•
